Summary

The intracardiac echocardiography devices market was valued at $301.7 million in 2023, and is projected to reach $801.6 million by 2033, growing at a CAGR of 10.3% from 2024 to 2033.
Intracardiac echocardiography devices are advanced imaging tools used during minimally invasive cardiac procedures to provide real-time, high-resolution ultrasound images of the heart's interior structures. Unlike transthoracic or transesophageal echocardiography, intracardiac echocardiography devices involve catheters with miniature ultrasound transducers inserted directly into the heart via venous access, enabling precise visualization of cardiac anatomy and procedural guidance without requiring general anesthesia.

The global intracardiac echocardiography devices market is witnessing robust growth due to factors such as alarming rise in prevalence of cardiovascular diseases and heightened the demand for precise imaging technologies during interventional procedures. According to a recent study published by the World Health Organization, cardiovascular diseases are the leading cause of death globally. Approximately 17.9 million individuals die each year due to cardiovascular diseases. In addition, the shift toward minimally invasive cardiac interventions, such as catheter-based ablation and transcatheter valve therapies, is driving the demand for intracardiac echocardiography devices, which provide real-time imaging to guide these procedures with precision and safety. Furthermore, surge in geriatric population acts as a key driving force of the global market. This is attributed to the fact that aged individuals are highly susceptible to cardiac conditions requiring interventional treatment. A 2024 study published by the World Health Organization revealed that the number of aged individuals will increase from 1 billion in 2020 to 1.4 billion by 2030. Moreover, the number of individuals aging 80 years and older is estimated to reach 426 million by 2050. Moreover, increase in focus on radiation-free imaging modalities significantly contributes toward the market growth. Intracardiac echocardiography devices reduce the reliance on fluoroscopy during cardiac interventions, addressing concerns about radiation exposure for both patients and healthcare providers. However, high cost associated with intracardiac echocardiography devices and procedures hampers the market growth. Moreover, limited availability of trained cardiologists and interventionalists capable of utilizing this technology effectively poses a barrier to broader adoption. On the contrary, innovations such as 3D and 4D imaging capabilities, enhanced catheter designs, and improved ultrasound resolution have significantly expanded the application of ICE devices, increasing their adoption among healthcare providers. Such developments are expected to offer lucrative opportunities for the expansion of the global market during the forecast period.

The global intracardiac echocardiography devices industry is segmented into application, end user, and region. On the basis of application, the market is classified into electrophysiology, left atrial appendage closure, transcatheter aortic valve implantation, MitraClip implantation, mitral valvuloplasty, and others. By end user, it is divided into hospitals, diagnostic centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings
On the basis of application, the electrophysiology segment is expected to dominate the market from 2024 to 2033.
By end user, the hospitals segment is anticipated to exhibit the highest growth in the global market throughout the forecast period.
Region wise, North America held the largest market share, in terms of revenue, in 2023, and is expected to dominate the market during the forecast period.

Competition Analysis
Competitive analysis and profiles of the major players in the global intracardiac echocardiography devices Market include GE Healthcare, Johnson & Johnson, Biomerics, LLC., Boston Scientific Corporation, Conavi Medical, Infraredx Inc., Koninklijke Philips NV, Siemens Healthcare GmbH, Fujifilm Corporation, Abbott Laboratories. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and strengthen their foothold in the global market.


Additional benefits you will get with this purchase are:
● Quarterly Update and* (only available with a corporate license, on listed price)
● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
● Free Upcoming Version on the Purchase of Five and Enterprise User License.
● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
● Free data Pack on the Five and Enterprise User License. (Excel version of the report)
● Free Updated report if the report is 6-12 months old or older.
● 24-hour priority response*
● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
● Additional company profiles with specific to client's interest
● Expanded list for Company Profiles
● Historic market data
Key Market Segments
By Application
● Electrophysiology
● Left Atrial Appendage Closure
● Transcatheter Aortic Valve Implantation
● MitraClip Implantation
● Mitral Valvuloplasty
● Others
By End User
● Hospitals
● Diagnostic Centers
● Others
By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ France
○ Germany
○ Italy
○ Spain
○ UK
○ Rest of Europe
● Asia-Pacific
○ China
○ Japan
○ India
○ South Korea
○ Australia
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ South Africa
○ Saudi Arabia
○ Rest of LAMEA
● Key Market Players
○ GE Healthcare
○ Johnson & Johnson
○ Biomerics, LLC.
○ Boston Scientific Corporation
○ Conavi Medical
○ Infraredx Inc.
○ Koninklijke Philips NV
○ Siemens Healthcare GmbH
○ Fujifilm Corporation
○ Abbott Laboratories

ページTOPに戻る

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: INTRACARDIAC ECHOCARDIOGRAPHY DEVICES MARKET, BY APPLICATION
4.1. Market Overview
4.1.1 Market Size and Forecast, By Application
4.2. Electrophysiology
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Left Atrial Appendage Closure
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Transcatheter Aortic Valve Implantation
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. MitraClip Implantation
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. Mitral Valvuloplasty
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
4.7. Others
4.7.1. Key Market Trends, Growth Factors and Opportunities
4.7.2. Market Size and Forecast, By Region
4.7.3. Market Share Analysis, By Country
CHAPTER 5: INTRACARDIAC ECHOCARDIOGRAPHY DEVICES MARKET, BY END USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End User
5.2. Hospitals
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Diagnostic Centers
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Others
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
CHAPTER 6: INTRACARDIAC ECHOCARDIOGRAPHY DEVICES MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Application
6.2.3. Market Size and Forecast, By End User
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Intracardiac Echocardiography Devices Market
6.2.5.1. Market Size and Forecast, By Application
6.2.5.2. Market Size and Forecast, By End User
6.2.6. Canada Intracardiac Echocardiography Devices Market
6.2.6.1. Market Size and Forecast, By Application
6.2.6.2. Market Size and Forecast, By End User
6.2.7. Mexico Intracardiac Echocardiography Devices Market
6.2.7.1. Market Size and Forecast, By Application
6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Application
6.3.3. Market Size and Forecast, By End User
6.3.4. Market Size and Forecast, By Country
6.3.5. France Intracardiac Echocardiography Devices Market
6.3.5.1. Market Size and Forecast, By Application
6.3.5.2. Market Size and Forecast, By End User
6.3.6. Germany Intracardiac Echocardiography Devices Market
6.3.6.1. Market Size and Forecast, By Application
6.3.6.2. Market Size and Forecast, By End User
6.3.7. Italy Intracardiac Echocardiography Devices Market
6.3.7.1. Market Size and Forecast, By Application
6.3.7.2. Market Size and Forecast, By End User
6.3.8. Spain Intracardiac Echocardiography Devices Market
6.3.8.1. Market Size and Forecast, By Application
6.3.8.2. Market Size and Forecast, By End User
6.3.9. UK Intracardiac Echocardiography Devices Market
6.3.9.1. Market Size and Forecast, By Application
6.3.9.2. Market Size and Forecast, By End User
6.3.10. Rest Of Europe Intracardiac Echocardiography Devices Market
6.3.10.1. Market Size and Forecast, By Application
6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Application
6.4.3. Market Size and Forecast, By End User
6.4.4. Market Size and Forecast, By Country
6.4.5. China Intracardiac Echocardiography Devices Market
6.4.5.1. Market Size and Forecast, By Application
6.4.5.2. Market Size and Forecast, By End User
6.4.6. Japan Intracardiac Echocardiography Devices Market
6.4.6.1. Market Size and Forecast, By Application
6.4.6.2. Market Size and Forecast, By End User
6.4.7. India Intracardiac Echocardiography Devices Market
6.4.7.1. Market Size and Forecast, By Application
6.4.7.2. Market Size and Forecast, By End User
6.4.8. South Korea Intracardiac Echocardiography Devices Market
6.4.8.1. Market Size and Forecast, By Application
6.4.8.2. Market Size and Forecast, By End User
6.4.9. Australia Intracardiac Echocardiography Devices Market
6.4.9.1. Market Size and Forecast, By Application
6.4.9.2. Market Size and Forecast, By End User
6.4.10. Rest of Asia-Pacific Intracardiac Echocardiography Devices Market
6.4.10.1. Market Size and Forecast, By Application
6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Application
6.5.3. Market Size and Forecast, By End User
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Intracardiac Echocardiography Devices Market
6.5.5.1. Market Size and Forecast, By Application
6.5.5.2. Market Size and Forecast, By End User
6.5.6. South Africa Intracardiac Echocardiography Devices Market
6.5.6.1. Market Size and Forecast, By Application
6.5.6.2. Market Size and Forecast, By End User
6.5.7. Saudi Arabia Intracardiac Echocardiography Devices Market
6.5.7.1. Market Size and Forecast, By Application
6.5.7.2. Market Size and Forecast, By End User
6.5.8. Rest of LAMEA Intracardiac Echocardiography Devices Market
6.5.8.1. Market Size and Forecast, By Application
6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. GE Healthcare
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Johnson And Johnson
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Biomerics, LLC.
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Boston Scientific Corporation
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Conavi Medical
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Infraredx Inc.
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Koninklijke Philips NV
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Siemens Healthcare GmbH
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Fujifilm Corporation
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Abbott Laboratories
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments